Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Meguro

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|November 14, 2017
One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetesJun Nojima, Shu Meguro, Naoto Ohkawa, et al.
Journal of Diabetes Investigation|July 1, 2026
Developing a machine learning model to predict renal function decline within three years using one-year longitudinal data in patients with type 2 diabetesMari Kaneda, Shu Meguro, Kaiken Kimura, et al.
Upsala Journal of Medical Sciences|January 18, 2012
A case of hypoglycemic hemiparesis and literature reviewTetsuhiro Yoshino, Shu Meguro, Yukie Soeda, et al.
BMC Public Health|October 15, 2024
Association of fish intake with all-cause mortality according to CRP levels or inflammation in older adults: a prospective cohort studyHideaki Kurata, Shu Meguro, Yukiko Abe, et al.
Diabetology International|August 5, 2024
A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetesRie Kaneshima Tamura, Noriko Kodani, Arata Itoh, et al.
Journal of Diabetes Investigation|November 14, 2024
A machine learning model for predicting worsening renal function using one-year time series data in patients with type 2 diabetesMari Watanabe, Shu Meguro, Kaiken Kimura, et al.
International Journal of Endocrinology|April 17, 2014
Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 TachyphylaxisShu Meguro, Toshihide Kawai, Tomohiro Matsuhashi, et al.
Geroscience|February 9, 2026
Kidney function and all-cause mortality in the oldest-old population: a three-cohort longitudinal studyHideaki Kurata, Shu Meguro, Yukiko Abe, et al.
BMC Geriatrics|August 9, 2023
Dietary protein intake and all-cause mortality: results from The Kawasaki Aging and Wellbeing ProjectHideaki Kurata, Shu Meguro, Yukiko Abe, et al.
Endocrine Research|May 25, 2012
A new preventive strategy for hypoglycemia incorporating added food diet in patients with type 2 diabetes who received sitagliptin therapyShu Meguro, Motoaki Sano, Toshihide Kawai, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|November 14, 2017
One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetesJun Nojima, Shu Meguro, Naoto Ohkawa, et al.
Journal of Diabetes Investigation|July 1, 2026
Developing a machine learning model to predict renal function decline within three years using one-year longitudinal data in patients with type 2 diabetesMari Kaneda, Shu Meguro, Kaiken Kimura, et al.
Upsala Journal of Medical Sciences|January 18, 2012
A case of hypoglycemic hemiparesis and literature reviewTetsuhiro Yoshino, Shu Meguro, Yukie Soeda, et al.
BMC Public Health|October 15, 2024
Association of fish intake with all-cause mortality according to CRP levels or inflammation in older adults: a prospective cohort studyHideaki Kurata, Shu Meguro, Yukiko Abe, et al.
Diabetology International|August 5, 2024
A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetesRie Kaneshima Tamura, Noriko Kodani, Arata Itoh, et al.
Journal of Diabetes Investigation|November 14, 2024
A machine learning model for predicting worsening renal function using one-year time series data in patients with type 2 diabetesMari Watanabe, Shu Meguro, Kaiken Kimura, et al.
International Journal of Endocrinology|April 17, 2014
Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 TachyphylaxisShu Meguro, Toshihide Kawai, Tomohiro Matsuhashi, et al.
Geroscience|February 9, 2026
Kidney function and all-cause mortality in the oldest-old population: a three-cohort longitudinal studyHideaki Kurata, Shu Meguro, Yukiko Abe, et al.
BMC Geriatrics|August 9, 2023
Dietary protein intake and all-cause mortality: results from The Kawasaki Aging and Wellbeing ProjectHideaki Kurata, Shu Meguro, Yukiko Abe, et al.
Endocrine Research|May 25, 2012
A new preventive strategy for hypoglycemia incorporating added food diet in patients with type 2 diabetes who received sitagliptin therapyShu Meguro, Motoaki Sano, Toshihide Kawai, et al.
Pageof 6